Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Technology
Share your love
Carl Zeiss Meditec to Acquire D.O.R.C.
Carl Zeiss Meditec AG announced that they have entered into an agreement to acquire 100% of the shares in D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. from Eurazeo SE, based in Paris, France. The deal is worth €985 million (nearly…
Sight Sciences Applauds Medicare’s MIGS Decision
Sight Sciences expressed its support for the decision made by five Medicare Administrative Contractors to withdraw their previously announced final local coverage determinations (LCDs) for Micro-Invasive Glaucoma Surgery, originally slated to become effective on January 29, 2024. The five MACs—WPS…
LVPEI and CORE Form Strategic Partnership
In a significant development in the field of eye care and vision science, the L.V. Prasad Eye Institute (LVPEI) and the Centre for Ocular Research & Education (CORE) at the University of Waterloo have established a strategic partnership. This alliance,…
Eye Exams May Track Neurodegeneration in Parkinson’s
Researchers from the University of the Basque Country (UPV/EHU) and Biobizkaia have explored the potential of using a common ophthalmological tool, optical coherence tomography, to monitor neurodegeneration in patients with Parkinson’s disease. This non-invasive method, commonly employed in eye health…
SalioGen Picks SGT-1001 for Stargardt Disease Development
SalioGen Therapeutics announced the selection of SGT-1001 as a development candidate for Stargardt disease treatment, a rare inherited retinal disease. This innovative therapy, SGT-1001, is designed as a one-time, non-viral intervention aimed at slowing or halting the progressive central vision…
New Treatment Slows Down Progression of AMD, RP
A breakthrough study has unveiled a promising advancement in the treatment of incurable eye diseases such as age-related macular degeneration and retinitis pigmentosa. Researchers have successfully integrated anti-inflammatory drugs into a hydrogel, aiming to combat inflammation in the retina while…
iHealthScreen Wins US Patent for Glaucoma AI Tool
iHealthScreen has been granted a full US patent for its iPredict glaucoma detection model by the US Patent and Trademark Office (USPTO) as of March 26, 2024. This advanced model leverages AI and color fundus imaging to provide swift and…
Ocular Therapeutix Reports Promising Axpaxli Results in DR Study
Ocular Therapeutix announced positive topline results from its phase 1 HELIOS study, which evaluated the safety, tolerability, and efficacy of Axpaxli versus a sham control in patients with moderately severe to severe nonproliferative diabetic retinopathy (NPDR) without diabetic macular edema…
Rare Cells Identified as Key to Color Perception
In a study published in the Journal of Neuroscience, researchers at the University of Rochester have made significant strides in understanding how humans perceive color. Utilizing adaptive optics, the team has identified rare retinal ganglion cells (RGCs) that could reshape…
New NIH Technology Enhances Retinal Disease Diagnosis
Researchers at the National Institutes of Health have significantly advanced retinal imaging by integrating artificial intelligence (AI) with adaptive optics (AO) and optical coherence tomography (OCT) technology. This new method, which they call parallel discriminator generative adverbial network (P-GAN), accelerates…